Filing Details
- Accession Number:
- 0001437749-17-020756
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-15 14:34:19
- Reporting Period:
- 2017-12-13
- Accepted Time:
- 2017-12-15 14:34:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 768710 | Reliv International Inc | RELV | Pharmaceutical Preparations (2834) | 371172197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 902108 | L Robert Montgomery | 136 Chesterfield Industrial Boulevard Chesterfield MO 63005 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Reliv International, Inc. | Acquisiton | 2017-12-13 | 1,200 | $4.49 | 526,727 | No | 4 | P | Indirect | IRA |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | IRA |
Footnotes
- 1. Purchased pursuant to Rule 10B5-1 Plan
Billionaire Hedge Funds
